FDA Approves New Anti-Seizure Medication for Treatment-Resistant Focal Epilepsy

The FDA has approved cenobamate (Xcopri) expanded indication for adults with focal onset impaired awareness seizures that have not responded to at least two prior anti-seizure medications.